Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone plus Capecitabine in advanced breast cancer
NCT00082433Phase 3Completed
- Sponsor
- R-Pharm
- Start
- Nov 2003
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 29
01
Overview
Phase 3, randomised, open-label trial of ixabepilone in breast cancer (2 arms), sponsored by R-Pharm. Primary endpoint: Overall Survival. Started Nov 2003; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00082433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082433.